NAA60
Basic information
Region (hg38): 16:3443649-3486953
Previous symbols: [ "NAT15" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Basal ganglia calcification, idiopathic, 9, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 38480682 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAA60 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 10 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 2 | 1 |
Variants in NAA60
This is a list of pathogenic ClinVar variants found in the NAA60 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-3476241-T-C | not specified | Uncertain significance (Apr 17, 2023) | ||
16-3476259-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
16-3476277-T-G | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3476336-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
16-3479490-C-T | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3479541-G-A | not specified | Uncertain significance (Aug 25, 2021) | ||
16-3482528-C-T | Likely benign (Mar 01, 2020) | |||
16-3482581-TCAGGAAG-T | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3483362-G-C | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3483377-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
16-3483377-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
16-3483407-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
16-3483416-C-T | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3483453-A-C | Basal ganglia calcification, idiopathic, 9, autosomal recessive | Pathogenic (Apr 16, 2024) | ||
16-3483457-C-G | not specified | Uncertain significance (Aug 01, 2024) | ||
16-3483540-A-G | not specified | Uncertain significance (Apr 03, 2023) | ||
16-3483552-C-G | not specified | Uncertain significance (Nov 13, 2023) | ||
16-3483592-G-A | Uncertain significance (Jan 01, 2017) | |||
16-3484706-A-C | not specified | Uncertain significance (Jun 05, 2024) | ||
16-3484763-G-A | not specified | Likely benign (Feb 10, 2022) | ||
16-3484780-C-G | Benign (Dec 04, 2017) | |||
16-3484781-A-G | not specified | Uncertain significance (Mar 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAA60 | protein_coding | protein_coding | ENST00000407558 | 5 | 43353 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.517 | 0.480 | 124630 | 0 | 9 | 124639 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.929 | 111 | 142 | 0.781 | 0.00000813 | 1577 |
Missense in Polyphen | 13 | 39.609 | 0.32821 | 458 | ||
Synonymous | 0.0606 | 59 | 59.6 | 0.990 | 0.00000400 | 452 |
Loss of Function | 2.44 | 2 | 10.6 | 0.189 | 5.12e-7 | 127 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000646 | 0.0000646 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000950 | 0.0000928 |
European (Non-Finnish) | 0.0000370 | 0.0000354 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: N-alpha-acetyltransferase that specifically mediates the acetylation of N-terminal residues of the transmembrane proteins, with a strong preference for N-termini facing the cytosol (PubMed:25732826). Displays N-terminal acetyltransferase activity towards a range of N-terminal sequences including those starting with Met-Lys, Met-Val, Met-Ala and Met-Met (PubMed:21750686, PubMed:25732826, PubMed:27550639, PubMed:27320834). Required for normal chromosomal segregation during anaphase (PubMed:21750686). May also show histone acetyltransferase activity; such results are however unclear in vivo and would require additional experimental evidences (PubMed:21981917). {ECO:0000269|PubMed:21750686, ECO:0000269|PubMed:25732826, ECO:0000269|PubMed:27320834, ECO:0000269|PubMed:27550639, ECO:0000305|PubMed:21981917}.;
Recessive Scores
- pRec
- 0.0989
Intolerance Scores
- loftool
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Naa60
- Phenotype
Gene ontology
- Biological process
- nucleosome assembly;N-terminal protein amino acid acetylation;chromosome segregation;cell population proliferation;N-terminal peptidyl-methionine acetylation;histone H3 acetylation;histone H4 acetylation
- Cellular component
- Golgi membrane
- Molecular function
- peptide alpha-N-acetyltransferase activity;H4 histone acetyltransferase activity;protein homodimerization activity